In this study, the level of SP-D in the pARDS group was significantly higher than in both the non-pARDS group and the control group, and further elevated at diagnosis, indicating that SP-D levels may show an increasing trend early in the disease course.
← all excerpts
Risk assessment of pARDS in severe pneumonia patients based on lung injury prediction scores and serum biomarkers.
1
—
—